Madhavi Rudraraju, MD
Transplant Hepatology · San Antonio, TXNPI 1609803956
Payments from drug & device makers
Across 864 payments — averaging $9286.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$1.7M
- Madrigal Pharmaceuticals$1.4M
- Genentech, Inc.$812K
- GSK$737K
- Takeda Pharmaceuticals U.S.A., Inc.$624K
- Amgen$591K
- plus $2.2M from 16 others
Across 5 payments — averaging $207.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1K
What the payments were for
- Consulting fees$7502%
- Speaking & faculty fees$35,09286%
- Travel & lodging$3,7089%
- Food & beverage$1,4584%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 38 | $1,669,290 |
| Madrigal Pharmaceuticals | 225 | $1,424,506 |
| Genentech, Inc. | 41 | $812,158 |
| GSK | 172 | $736,923 |
| Takeda Pharmaceuticals U.S.A., Inc. | 68 | $624,485 |
| Amgen | 6 | $590,731 |
| Astrazeneca UK Limited | 7 | $373,271 |
| Gilead | 22 | $314,426 |
| Boehringer Ingelheim | 3 | $310,668 |
| PTC Therapeutics, Inc. | 27 | $286,208 |
| Boehringer Ingelheim International GmbH | 219 | $255,502 |
| Incyte Corporation | 11 | $241,281 |
| AstraZeneca | 4 | $161,286 |
| Dexcom, Inc. | 7 | $75,944 |
| Intercept Pharma Europe Ltd. | 1 | $58,722 |
| Braintree Laboratories, Inc. | 5 | $56,861 |
| Mallinckrodt Enterprises LLC | 1 | $19,866 |
| Mallinckrodt Hospital Products Inc. | 3 | $7,817 |
| Boehringer Ingelheim RCV GmbH & Co KG | 1 | $2,836 |
| Shionogi Inc | 1 | $750 |
| Novo Nordisk | 1 | $120 |
| Veloxis Pharmaceuticals, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,023,671 in reported general payments places this provider in the 95th percentile of 28 transplant hepatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant hepatology in San Antonio
- Carmen LandaverdeSan Antonio$757K
- Kamran SafdarSan Antonio$4K
- Omer JunaidiSan Antonio$1K
- Hakan AkinSan Antonio$235
- Erin SpenglerSan Antonio$76
- Abdullah MubarakTyler$4.2M
- Mangesh PagadalaDallas$1.9M
- David VictorHouston$1.3M
- Prasun JalalHouston$941K
- Fernando MembrenoMcAllen$736K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.